Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Lear (LEA)

Lear Q2 2024 EPS rises to $3.02 from $2.84; updates full-year 2024 outlook

Positive Impact 4 of 5 earnings Written later

Lear reported second-quarter 2024 sales of $6.0 billion, a modest increase from $5.999 billion a year earlier, and net income attributable to Lear of $173 million, up from $169 million. Diluted EPS was $3.02 versus $2.84, and adjusted EPS rose 8% to $3.60, which the company attributes mainly to its share repurchase program. The company also updated its full-year 2024 outlook, now showing core operating earnings of $1,030 million to $1,200 million, though the filing does not state the prior outlook for comparison.

Key points

  • Q2 2024 sales of $6.0 billion versus $5.999 billion in Q2 2023; core operating earnings flat at $302 million
  • Diluted EPS of $3.02 versus $2.84; adjusted EPS of $3.60 versus $3.33, up 8%
  • Full-year 2024 outlook: net sales $23,230 million to $23,670 million; core operating earnings $1,030 million to $1,200 million; free cash flow $485 million to $635 million
  • Repurchased $60 million of shares in Q2 2024; remaining authorization about $1.4 billion

The filing

CompanyLear (LEA)
Form8-K, current report
Filed with the SECJul 25, 2024, 7:01 AM ET
Accession number0000842162-24-000047

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 25, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.